Investigating the effects of statins on cellular lipid metabolism using a yeast expression system

13Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

In humans, defects in lipid metabolism are associated with a number of severe diseases such as atherosclerosis, obesity and type II diabetes Hypercholesterolemia is a primary risk factor for coronary artery disease, the major cause of premature deaths in developed countries Statins are inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the key enzyme of the sterol synthesis pathway Since yeast Saccharomyces cerevisiae harbours many counterparts of mammalian enzymes involved in lipid-synthesizing pathways, conclusions drawn from research with this single cell eukaryotic organism can be readily applied to higher eukaryotes Using a yeast strain with deletions of both HMG1 and HMG2 genes (i.e completely devoid of HMGR activity) with introduced wild-type or mutant form of human HMGR (hHMGR) gene we investigated the effects of statins on the lipid metabolism of the cell The relative quantification of mRNA demonstrated a different effect of simvastatin on the expression of the wild-type and mutated hHMGR gene GC/MS analyses showed a significant decrease of sterols and enhanced conversion of squalene and sterol precursors into ergosterol This was accompanied by the mobilization of ergosterol precursors localized in lipid particles in the form of steryl esters visualized by confocal microscopy Changes in the level of ergosterol and its precursors in cells treated with simvastatin depend on the mutation in the hHMGR gene HPLC/MS analyses indicated a reduced level of phospholipids not connected with the mevalonic acid pathway We detected two significant phenomena First, cells treated with simvastatin develop an adaptive response compensating the lower activity of HMGR This includes enhanced conversion of sterol precursors into ergosterol, mobilization of steryl esters and increased expression of the hHMGR gene Second, statins cause a substantial drop in the level of glycerophospholipids. © 2009 Leszczynska et al.

References Powered by Scopus

A new mathematical model for relative quantification in real-time RT–PCR

28540Citations
N/AReaders
Get full text

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

7233Citations
N/AReaders
Get full text

Pleiotropic effects of statins

1535Citations
N/AReaders
Get full text

Cited by Powered by Scopus

In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

152Citations
N/AReaders
Get full text

Effects of a common pharmaceutical, atorvastatin, on energy metabolism and detoxification mechanisms of a marine bivalve Mytilus edulis

66Citations
N/AReaders
Get full text

Saccharomyces cerevisiae as a tool for mining, studying and engineering fungal polyketide synthases

49Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Leszczynska, A., Burzynska, B., Plochocka, D., Kaminska, J., Zimnicka, M., Kania, M., … Szkopinska, A. (2009). Investigating the effects of statins on cellular lipid metabolism using a yeast expression system. PLoS ONE, 4(12). https://doi.org/10.1371/journal.pone.0008499

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

42%

Researcher 13

42%

Professor / Associate Prof. 5

16%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 22

63%

Biochemistry, Genetics and Molecular Bi... 8

23%

Chemistry 3

9%

Medicine and Dentistry 2

6%

Save time finding and organizing research with Mendeley

Sign up for free